NexImmune, Inc.
Pharmaceutical company · Gaithersburg, Maryland, United States
NexImmune, Inc. is a pharmaceutical company headquartered in Gaithersburg, Maryland, United States. Its earliest recorded incorporation is in 2011. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $288,268 in total, most recently in 2013. It has reported private securities offerings to the US SEC, most recently $7.8 million sold in a notice filed in 2019.
NexImmune at a glance
What does NexImmune do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $288,268 in total (2013).
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $7.8 million sold (2019).
Frequently asked questions about NexImmune
Where is NexImmune headquartered?
NexImmune, Inc. is headquartered in Gaithersburg, Maryland, United States.
What does NexImmune do?
NexImmune, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
When was NexImmune founded?
The earliest incorporation on record for NexImmune, Inc. is in 2011, according to public company registers.
Similar companies
- Emergent BioSolutions Inc.Gaithersburg, Maryland, United States
- Genvec IncGaithersburg, Maryland, United States
- Altimmune, Inc.Gaithersburg, Maryland, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.